Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Citrin Website

Deborah E. Citrin, M.D.

Selected Publications

1)  Citrin DE, Shankavaram U, Horton JA, Shield W, Zhao S, Asano H, White A, Sowers A, Thetford A, Chung EJ.
Role of Type II Pneumocyte Senescence in Radiation-Induced Lung Fibrosis.
J. Natl. Cancer Inst. 105: 1474-1484, 2013.
[Journal]
2)  Horton JA, Hudak KE, Chung EJ, White AO, Scroggins BT, Burkeen JF, Citrin DE.
Mesenchymal stem cells inhibit cutaneous radiation-induced fibrosis by suppressing chronic inflammation.
Stem Cells. 2013.
[Journal]
3)  Urick ME, Chung EJ, Shield WP, Gerber N, White A, Sowers A, Thetford A, Camphausen K, Mitchell J, Citrin DE.
Enhancement of 5-Fluorouracil-induced In Vitro and In Vivo Radiosensitization with MEK Inhibition.
Clin Cancer Res. [Epub ahead of print], 2011.
[Journal]
4)  Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC, Mitchell JB.
Radioprotectors and mitigators of radiation-induced normal tissue injury.
Oncologist. 15: 360-71, 2010.
[Journal]
5)  Chung EJ, Brown AP, Asano H, Mandler M, Burgan WE, Carter D, Camphausen K, Citrin D.
In vitro and in vivo radiosensitization with AZD6244 (ARRY-142886), an inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 kinase.
Clin. Cancer Res. 15: 3050-7, 2009.
[Journal]
6)  Citrin D, Camphausen KA.
Biomarkers for prostate cancer: who will benefit from local treatment, who harbors occult systemic disease and who needs treatment at all?.
Biomark Med. 7: 823-5, 2013.
[Journal]
7)  Horton J, Li F, Chung EJ, Hudak K, White A, Krausz K, Gonzalez F, Citrin D.
Quercetin Inhibits Radiation-Induced Skin Fibrosis.
Radiat. Res. 2013.
[Journal]
8)  Citrin D, Hudak K, Camphausen KA.
Biomarkers to guide therapy or surveillance for prostate cancer.
Biomark Med. 7: 827-9, 2013.
[Journal]
9)  Gamrekelashvili J, Kapanadze T, Han M, Wissing J, Ma C, Jaensch L, Manns MP, Armstrong T, Jaffee E, White AO, Citrin DE, Korangy F, Greten TF.
Peptidases released by necrotic cells control CD8+ T cell cross-priming.
J. Clin. Invest. 2013.
[Journal]
10)  Prager AJ, Peng CR, Lita E, McNally D, Kaushal A, Sproull M, Compton K, Dahut WL, Figg WD, Citrin D, Camphausen KA.
Urinary aHGF, IGFBP3 and OPN as diagnostic and prognostic biomarkers for prostate cancer.
Biomark Med. 7: 831-41, 2013.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 12/30/2013.